Clinical Trial Update: To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/Phase 3 clinical trial evaluating IAH0968 in combination with CAPEOX for HER2-positive gastric cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stomach Neoplasms

Drugs mentioned

• CAPEOX
• IAH0968 (IAH0968)

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: Stomach Neoplasms, Solid Tumor | Phase 2, Phase 3 | Status: RECRUITING